Articles, guides, and regulatory updates from our community.
A 2026 ACS Nano study suggests mitochondria-targeted nanoparticles may reduce liver ischemia-reperfusion injury by limiting ROS and inflammation in mice.
By Peptide Association Research Team
New research suggests IL-15 combined with Thymosin α1 may reverse immune cell aging in liver cancer. Learn what this preclinical study found.
By Peptide Association Research Team
New research suggests elamipretide (SS-31) may support recovery after spinal cord injury by protecting mitochondria and reducing cell death. Learn what the study found.
By Peptide Association Research Team